WIRELESS LAN (LOCAL AREA NETWORK) - WIRELESS ETHERNET

K971683 · Marquette Electronics, Inc. · MSX · Oct 22, 1997 · Cardiovascular

Device Facts

Record IDK971683
Device NameWIRELESS LAN (LOCAL AREA NETWORK) - WIRELESS ETHERNET
ApplicantMarquette Electronics, Inc.
Product CodeMSX · Cardiovascular
Decision DateOct 22, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.2300
Device ClassClass 2

Indications for Use

The Marquette Eagle 4000 Patient Monitor is a multi-parameter patient monitoring system that is cleared to market as part of Marquette's wired Unity network. The Marquette Eagle 4000 Patient Monitor is now indicated for use on Marquette's wireless LAN. Wireless LAN is a method of communicating to the Marquette Unity Network using a wireless connection. This capability: ~provides identical networking function to standard Ethernet; ~permits integration to the network without physical connection to the Ethernet wall plate. This device is viewed as a technology change and can be used with various other Marquette devices. Marquette has clearances for various patient monitors and its central station which are part of its wired Unity network. The intended patient population is limited to the same population as the device that the technology is being used with. This device should be used by people who are trained in the use of the equipment. This device is intended to be used within the hospital / facility environment.

Device Story

Wireless LAN (Local Area Network) technology for Marquette Unity Network; enables wireless communication for Marquette patient monitors (e.g., Eagle 4000) and central stations; replaces physical Ethernet wall plate connection with wireless link; provides identical networking functionality to standard wired Ethernet; used in hospital/facility environments by trained clinical staff; allows integration of patient monitoring data into existing network infrastructure without physical tethering; facilitates continuous patient monitoring and data transmission to central stations; benefits include increased mobility and flexible placement of monitoring equipment within clinical settings.

Clinical Evidence

Bench testing only. Verification and validation testing compared wireless LAN performance to wired LAN performance on the Eagle 4000 Patient Monitor. Testing confirmed compliance with IEC 601-1-1 (safety), IEEE C95.1-1991 (RF exposure), CISPR 11 Class A (EMC), and IEC 1000-4 series/MIL-STD 462D (immunity). Results indicate equivalent performance to wired systems.

Technological Characteristics

Wireless Ethernet networking module; operates within hospital/facility environments; complies with IEEE C95.1-1991 for RF exposure; meets CISPR 11 Class A for emissions and IEC 1000-4/MIL-STD 462D for immunity; provides identical networking function to standard Ethernet; integrates with existing Marquette Unity Network infrastructure.

Indications for Use

Indicated for patients requiring multi-parameter monitoring in hospital or clinical facility environments, consistent with the population indicated for the specific Marquette patient monitor or central station device being used.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K971683 # 510(k) Summary of Safety and Effectiveness ### Manufacturer / Submitter 1. OCT 2 2 1997 Marquette Medical Systems 8200 West Tower Avenue Milwaukee, WI 53223 USA Establishment Registration Number 2124823 Contact Name / Telephone Number Dianne Schmitz Corporate Regulatory Affairs Marquette Medical Systems Phone: (414) 362-3230 Date: 21 April 97 #### 2. General Information ## Trade/Proprietary Name There is no trade/ proprietary name that will be associated with this technology change. Marquette will refer to it as wireless LAN (Local Area Network) - wireless Ethernet. ## Common/Usual Name This device is commonly known as wireless networking. ## Device Classification The wireless LAN technology change may be used with devices which are Class III, therefore, it will remain in Class III. The modified device that is the subject of this 510(k) submission is a Class III device. ## Performance Standards Peformance standards (Section 514 of the Act) have not yet been established for the device that is the subject of this premarket notification submission. ### Legally Marketed Predicate Device(s) 3. The device chosen to be used to demonstrate SE for the wireless LAN capability was the Eagle 4000 Patient Monitor. Support testing compared the Eagle 4000 using wired LAN to the Eagle 4000 using wireless LAN. Its 510(k) equivalency references include the following: | K912799 | Eagle System | |---------|----------------------------| | K920790 | Eagle Monitor | | K964750 | Eagle 4000 Patient Monitor | {1}------------------------------------------------ ### 4. Device Description The Marquette Eagle 4000 Patient Monitor is a multi-parameter patient monitoring system that is cleared to market as part of Marquette's wired Unity network. The Marquette Eagle 4000 Patient Monitor is now indicated for use on Marquette's wireless LAN. Wireless LAN is a method of communicating to the Marquette Unity Network using a wireless connection. This capability: ~provides identical networking function to standard Ethernet; ~permits integration to the network without physical connection to the Ethernet wall plate. ### 5. Intended Use This device is viewed as a technology change and can be used with various other Marquette devices. Marquette has clearances for various patient monitors and its central station which are part of its wired Unity network. The intended patient population is limited to the same population as the device that the technology is being used with. This device is intended to be used within the hospital / facility environment. ### 6. Brief Description of Testing & Conclusion The Wireless LAN device when used in conjunction with the patient monitor meets the safety requirements of IEC 601-1-1. It also meets the requirements of IEEE Standard for Safety Levels with Respect to Human Exposure to Radio Frequency Electromagnetic Fields, 3 kHz to 300 GHz (IEEE C95.1-1991) and has the appropriate FCC certification. Electromagnetic compatibility testing demonstrates that the device meets the reauirements of CISPR 1 1 Class A for both radiated and conducted emissions. Immunity testing demonstrates that the device meets the requirements of the IEC 1000-4 series and MIL-STD 462D. Verification and validation testing was done on the wireless LAN in use with the Eagle 4000 Patient Monitor. Test results indicate that the Eagle 4000 Patient Monitor with wireless LAN provides an equivalent level in performance, when compared to the Eagle 4000 Patient Monitor with wired LAN, when tested to the accuracy requirements as specified in the contents of the premarket notification submission. Marquette Medical Systems has demonstrated that use of the wireless LAN capability in its devices is as safe and effective, and performs substantially equivalent to use of the wired LAN in its devices. {2}------------------------------------------------ Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized design of three human profiles facing to the right. The profiles are stacked on top of each other, creating a sense of depth and unity. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the design. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT 2 2 1997 Ms. Dianne Schmitz Marquette Medical Systems 8200 West Tower Avenue Milwaukee, Wisconsin 53223 K971683 Re : Marquette Wireless LAN (Local Area Network) Wireless Ethernet III (three) Requlatory Class: Product Code: 74 MSX Dated: August 26, 1997 Received: August 27, 1997 Dear Ms. Schmitz: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to,895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ ### Page 2 - Ms. Dianne Schmitz This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Thomas J. Callahon Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number: K971683 Device Name: Marquette Wireless LAN (Local Area Network) Wireless Ethernet Indications For Use: The Marquette Eagle 4000 Patient Monitor is a multi-parameter patient monitoring system that is cleared to market as part of Marquette's wired Unity network. The Marquette Eagle 4000 Patient Monitor is now indicated for use on Marquette's wireless LAN. Wireless LAN is a method of communicating to the Marquette Unity Network using a wireless connection. This capability: ~provides identical networking function to standard Ethernet; ~permits integration to the network without physical connection to the Ethernet wall plate. This device is viewed as a technology change and can be used with various other Marquette devices. Marquette has clearances for various patient monitors and its central station which are part of its wired Unity network. The intended patient population is limited to the same population as the device that the technology is being used with. This device should be used by people who are trained in the use of the equipment. This device is intended to be used within the hospital / facility environment. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) A.A. Ciarkowski (Division Sign-Off) (Division Sign-Off) Division of Cardiovascular, Respiratory, Division of Cardios) Devices Division of Caralo. and Neurological Devices OR 510(k) Number _ Over-The-Counter Use (Optional Format 1-2-96) Prescription Use (Per 21 CFR 801.109) (W
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...